Filing Details
- Accession Number:
- 0000950170-24-137960
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-18 16:51:42
- Reporting Period:
- 2024-12-16
- Accepted Time:
- 2024-12-18 16:51:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1812364 | Relay Therapeutics Inc. | RLAY | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816210 | Sanjiv Patel | C/O Relay Therapeutics, Inc. 399 Binney Street, 2Nd Floor Cambridge MA 02142 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-16 | 100,000 | $5.00 | 574,548 | No | 4 | S | Indirect | By The Patel Family Irrevocable Trust of 2019 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By The Patel Family Irrevocable Trust of 2019 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 766,130 | Direct | |
| Common Stock | 687,355 | Indirect | By The SSP Irrevocable Trust of 2020 |
Footnotes
- These shares were sold by the Patel Family Irrevocable Trust of 2019 (the "Trust") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024.
- These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- Includes 762,360 shares underlying restricted stock units.
- These shares are held in an irrevocable trust for the benefit of the reporting person's family members. An independent trustee is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
